PEDRO RODRIGUEZ: Open Payments
NPI 1386710572 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,365 in 77 payments from 13 companies in 2025. Trend: 2023 $12,221 · 2024 $8,852 · 2025 $7,365
Speaker / faculty: $5,500Food & beverage: $1,865
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $6,057 |
| Vanda Pharmaceuticals Inc. | 11 | $285 |
| Lundbeck LLC | 9 | $195 |
| E.R. Squibb & Sons, L.L.C. | 8 | $186 |
| Otsuka America Pharmaceutical, Inc. | 8 | $180 |
| Alkermes, Inc. | 6 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| Tris Pharma Inc | 3 | $66 |
| Almatica Pharma LLC | 1 | $23 |
Products named: VRAYLAR, REXULTI, COBENFY, HETLIOZ, FANAPT, ARISTADA, CAPLYTA, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
